Blood C-reactive protein (CRP) has also been proposed as a marker of airway inflammation, but in a very limited cohort of non-smoker asthmatic patients without such additional complications as cardiovascular-related diseases, hyperlipidemia, chronic obstructive pulmonary disease (COPD), or infection [61]. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.